Tag Archive for ‘medical Stocks’

Tengion Inc.  (NASDAQ: TNGN) shares rallied 35.3% to $0.920 Monday, extending gains into a second day. Over 1.79 million shares traded, topping the 10-day average of 324.4 K. The stock is currently trading above its 50-day and 200-day moving averages of $0.47 and $0.78, respectively.  Market capitalization currently stands at 21.78 million and it has 23.67 million outstanding shares. Shares - Continue Reading »

Shares of Cardium Therapeutics Inc. (AMEX: CXM) traded higher on news the company has inked its first international deal for the commercialization of Excellagen in South Korea. The stock saw trading volume hit 2.87 million shares Thursday, topping 10-day average of over 213 K. Shares closed the session at $0.35, above the 50-day and 200-day moving averages of $0.32 and - Continue Reading »

Shares of specialty pharmaceutical company BioSante Pharmaceuticals Inc. (NASDAQ: BPAX) climbed as much as $0.55 Tuesday before closing the session at $0.52.  Over 7.53 million shares were traded. BPAX is currently trading below its 50-day and 200-day moving averages of $2.02 and $2.53, respectively.  Market capitalization currently stands at 56.90 million and it has 110.01 million outstanding shares. - Continue Reading »

Sanmina-SCI Corp. (NASDAQ: SANM), an independent global provider of customized, integrated electronics manufacturing services (EMS), yesterday announced that its facility in Kenosha, Wisconsin, was awarded ISO 13485 certification for medical device manufacturing. The certification confirms the company’s world-class manufacturing capabilities, and its focus on meeting the highest level of quality assurance for products developed for the medical industry. - Continue Reading »

MELA Sciences (MELA) is a medical technology company focused on developing MelaFind, a non-invasive and objective multi-spectral computer vision system intended to aid in the detection of early melanoma.  The company designed MelaFind to assist in the evaluation of clinically atypical pigmented skin lesions when a dermatologist chooses to obtain additional information before making a final decision to biopsy in - Continue Reading »

Aeterna Zentaris Inc. (AEZS) is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer. The Company’s innovative approach of “personalized medicine” means tailoring treatments to a patient’s specific condition and to unmet medical needs. AEZS’s deep pipeline is drawn from its proprietary discovery unit providing the - Continue Reading »

PharmAthene Inc. (PIP) is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons. The Company’s lead product development programs include: SparVax, a second generation recombinant protective antigen (rPA) anthrax vaccine and a third generation anthrax vaccine with potential for improved potency and stability; Valortim, a fully human monoclonal antibody for the prevention - Continue Reading »

Radient Pharmaceuticals Corp. (RPC) is a Tustin, Calif.-based company focused on the discovery, development and commercialization of diagnostic tests that help physicians answer clinical questions related to early disease-state detection, treatment strategy and the monitoring of disease progression or recurrence. The Company offers its FDA-cleared In Vitro Diagnostic Onko-SureTest Kits for colon-rectal cancer recurrence monitoring. - Continue Reading »

Regeneron Pharmaceuticals Inc. (Nasdaq: REGN) shares soared 8.5% over the last trading week, after the U.S. Food and Drug Administration (FDA)  gave priority review status for the company’s ophthalmology drug candidate VEGF Trap-Eye. The medicine, which is being developed for the treatment of the neovascular form of age-related macular degeneration (wet AMD), was accepted for the FDA’s review and could - Continue Reading »

Biostar Pharmaceuticals Inc. (BSPM), through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company’s most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B, a disease affecting nearly 10% of the Chinese population. - Continue Reading »